Spravato Treatment in Phoenix: A New Hope for Treatment-Resistant Depression
Spravato (esketamine) is an FDA-approved treatment for individuals with treatment-resistant depression. Unlike traditional antidepressants, Spravato targets different brain pathways, offering a new approach for patients who have not found relief with other medications. At Revival Psychiatry in Phoenix, AZ, Spravato is administered in a medically supervised setting, ensuring patient safety and individualized care. The treatment involves a nasal spray used in conjunction with an oral antidepressant, providing a comprehensive approach to managing depression symptoms. 
